Matthew Abernethy

(Mr. Matthew Abernethy CPA)

Currently holds a position at Neurocrine Biosciences Inc

Positions

Position Company Period
Chief Financial Officer Neurocrine Biosciences Inc Nov. 29, 2017 -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-14 2025-02-13
PS Planned sale
1,206 -3.3%
116.87
USD 140,944 		1,206 -3.3% 116.87 USD 140,944
2025-02-14 2025-02-13
PS Planned sale
1,352 -3.7%
116.85
USD 157,979 		1,352 -3.7% 116.85 USD 157,979
2025-02-12 2025-02-10
PS Planned sale
980 -2.8%
118.27
USD 115,909 		980 -2.8% 118.27 USD 115,909
2025-02-04 2025-01-31
PS Planned sale
1,283 -3.8%
152.87
USD 196,136 		1,283 -3.8% 152.87 USD 196,136
2024-08-15 2024-08-13
PS Planned sale
14,100 -30.9%
150.38
USD 2,120,347 		14,100 -30.9% 150.38 USD 2,120,347
2024-07-18 2024-07-16
PS Planned sale
900 -2.8%
150.04
USD 135,037 		900 -2.8% 150.04 USD 135,037
2024-05-16 2024-05-15
PS Planned sale
15,000 -32.2%
140.24
USD 2,103,609 		15,000 -32.2% 140.24 USD 2,103,609
2024-05-16 2024-05-14
PS Planned sale
15,000 -32.2%
135.66
USD 2,034,827 		15,000 -32.2% 135.66 USD 2,034,827
2024-02-15 2024-02-13
PS Planned sale
1,352 -4.1%
132.85
USD 179,612 		1,352 -4.1% 132.85 USD 179,612
2024-02-08 2024-02-08
PS Planned sale
980 -3.1%
134.21
USD 131,529 		980 -3.1% 134.21 USD 131,529
2024-02-08 2024-02-06
PS Planned sale
1,280 -4.2%
142.19
USD 182,000 		1,280 -4.2% 142.19 USD 182,000
2024-02-02 2024-01-31
PS Planned sale
1,283 -4.3%
140.72
USD 180,539 		1,283 -4.3% 140.72 USD 180,539
2023-08-23 2023-08-21
PS Planned sale
2,132 -7.3%
107.39
USD 228,958 		2,132 -7.3% 107.39 USD 228,958
2023-02-08 2023-02-08
PS Planned sale
980 -3.7%
104.19
USD 102,110 		980 -3.7% 104.19 USD 102,110
2023-02-08 2023-02-07
PS Planned sale
11,491 -32.1%
102.40
USD 1,176,693 		11,491 -32.1% 102.40 USD 1,176,693
2023-02-08 2023-02-07
PS Planned sale
12,807 -26.3%
102.42
USD 1,311,688 		12,807 -26.3% 102.42 USD 1,311,688
2023-02-08 2023-02-07
PS Planned sale
2,030 -7.7%
102.33
USD 207,725 		2,030 -7.7% 102.33 USD 207,725
2023-02-08 2023-02-06
PS Planned sale
1,280 -5.4%
105.67
USD 135,253 		1,280 -5.4% 105.67 USD 135,253
2023-02-02 2023-01-31
PS Planned sale
1,283 -5.7%
109.98
USD 141,108 		1,283 -5.7% 109.98 USD 141,108
2022-02-09 2022-02-08
PS Planned sale
980 -4.6%
79.65
USD 78,058 		980 -4.6% 79.65 USD 78,058
2022-02-09 2022-02-07
PS Planned sale
1,280 -6.2%
80.78
USD 103,396 		1,280 -6.2% 80.78 USD 103,396
2022-02-09 2022-02-07
PS Planned sale
2,030 -10.0%
80.80
USD 164,032 		2,030 -10.0% 80.80 USD 164,032
2021-12-03 2021-12-01
PS Planned sale
1,645 -9.1%
82.59
USD 135,852 		1,645 -9.1% 82.59 USD 135,852
2021-02-09 2021-02-08
PS Planned sale
2,030 -12.0%
116.81
USD 237,116 		2,030 -12.0% 116.81 USD 237,116
2021-02-09 2021-02-08
PS Planned sale
880 -6.3%
116.85
USD 102,826 		880 -6.3% 116.85 USD 102,826
2020-12-02 2020-12-01
PS Planned sale
1,645 -12.5%
94.66
USD 155,721 		1,645 -12.5% 94.66 USD 155,721
2020-11-16 2020-11-12
PS Planned sale
2,257 -18.4%
90.74
USD 204,810 		2,257 -18.4% 90.74 USD 204,810
2020-08-07 2020-08-05
PS Planned sale
2,257 -22.0%
118.90
USD 268,356 		2,257 -22.0% 118.90 USD 268,356
2020-05-11 2020-05-07
PS Planned sale
15,000 -71.6%
110.21
USD 1,653,134 		15,000 -71.6% 110.21 USD 1,653,134
2020-04-30 2020-04-28
PS Planned sale
1,741 -22.6%
102.49
USD 178,435 		1,741 -22.6% 102.49 USD 178,435
2020-04-28 2020-04-24
PS Planned sale
1,934 -20.1%
99.52
USD 192,467 		1,934 -20.1% 99.52 USD 192,467
2020-02-11 2020-02-07
PS Planned sale
2,030 -26.3%
103.35
USD 209,807 		2,030 -26.3% 103.35 USD 209,807
2019-12-04 2019-12-02
PS Planned sale
1,645 -29.8%
116.33
USD 191,360 		1,645 -29.8% 116.33 USD 191,360
2018-12-06 2018-12-03
PS Planned sale
1,178 -37.7%
90.00
USD 106,020 		1,178 -37.7% 90.00 USD 106,020
// ... existing code ... // ... rest of the file ...